title: A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.
abstract: (18)F-FDG-PET has been widely used in patients with brain tumors. However, the reported sensitivity and specificity of (18)F-FDG-PET for brain tumor differentiation varied greatly. We performed this meta-analysis to systematically assess the diagnostic performance of (18)F-FDG-PET in differentiating brain tumors. The diagnostic performance of (11)C-methionine PET was assessed for comparison. Relevant studies were searched in PubMed/MEDLINE, Scopus, and China National Knowledge Infrastructure (until February 2013). The methodologic quality of eligible studies was evaluated, and a meta-analysis was performed to obtain the combined diagnostic performance of (18)F-FDG and (11)C-methionine PET with a bivariate model. Thirty eligible studies, including 5 studies with both (18)F-FDG and (11)C-methionine PET data were enrolled. Pooled sensitivity, pooled specificity, and area under the receiver operating characteristic curve of (18)F-FDG-PET (n = 24) for differentiating brain tumors were 0.71 (95% CI, 0.63-0.78), 0.77 (95% CI, 0.67-0.85), and 0.80. Heterogeneity was found among (18)F-FDG studies. Subsequent subgroup analysis revealed that the disease status was a statistically significant source of the heterogeneity and that the sensitivity in the patients with recurrent brain tumor was markedly higher than those with suspected primary brain tumors. Pooled sensitivity, pooled specificity, and area under the receiver operating characteristic of (11)C-methionine PET (n = 11) were 0.91 (95% CI, 0.85-0.94), 0.86 (95% CI, 0.78-0.92), and 0.94. No significant statistical heterogeneity was found among (11)C-methionine studies. This meta-analysis suggested that (18)F-FDG-PET has limited diagnostic performance in brain tumor differentiation, though its performance may vary according to the status of brain tumor, whereas (11)C-methionine PET has excellent diagnostic accuracy in brain tumor differentiation.
authors.affiliation: From the Department of Nuclear Medicine (C.Z., J.W.), Hangzhou First People's Hospital, Hangzhou Cancer Hospital, Hangzhou, China.
authors.forename: C
authors.initials: C
authors.lastname: Zhao
authors.affiliation: Department of Nuclear Medicine (Y.Z.), Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. zhy-lly@126.com.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: From the Department of Nuclear Medicine (C.Z., J.W.), Hangzhou First People's Hospital, Hangzhou Cancer Hospital, Hangzhou, China.
authors.forename: J
authors.initials: J
authors.lastname: Wang
mesh_terms: D001932:Brain Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology*; D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008715:Methionine / Q000187:drug effects*; D049268:Positron-Emission Tomography / Q000379:methods / Q000706:statistics & numerical data*; D015995:Prevalence; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods; D012680:Sensitivity and Specificity
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C086242:carbon-11 methionine; D008715:Methionine
references.citation: J Clin Epidemiol. 2008 Nov;61(11):1095-103
references.pmid: 19208372
references.citation: J Nucl Med. 2001 Mar;42(3):432-45
references.pmid: 11337520
references.citation: Clin Nucl Med. 2011 Nov;36(11):978-81
references.pmid: 21975383
references.citation: J Nucl Med. 2007 Oct;48(10):1651-61
references.pmid: 17873130
references.citation: AJNR Am J Neuroradiol. 1998 Mar;19(3):407-13
references.pmid: 9541290
references.citation: Clin Nucl Med. 2012 Sep;37(9):854-61
references.pmid: 22889774
references.citation: J Med Imaging Radiat Oncol. 2008 Dec;52(6):564-9
references.pmid: 19178630
references.citation: J Nucl Med. 2012 Feb;53(2):207-14
references.pmid: 22302961
references.citation: Ann Nucl Med. 2004 Jun;18(4):291-6
references.pmid: 15359921
references.citation: J Nucl Med. 2006 Jun;47(6):904-11
references.pmid: 16741298
references.citation: BMC Med Res Methodol. 2003 Nov 10;3:25
references.pmid: 14606960
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120
references.citation: J Nucl Med. 2007 Sep;48(9):1468-81
references.pmid: 17704239
references.citation: J Clin Epidemiol. 2005 Sep;58(9):882-93
references.pmid: 16085191
references.citation: Neuroimaging Clin N Am. 2002 Nov;12(4):615-26
references.pmid: 12687915
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Rev Esp Med Nucl. 2008 Sep-Oct;27(5):329-39
references.pmid: 18817662
references.citation: Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82
references.pmid: 11926379
references.citation: Stereotact Funct Neurosurg. 1999;73(1-4):9-14
references.pmid: 10853090
references.citation: Acad Radiol. 2010 Mar;17(3):282-90
references.pmid: 20060750
references.citation: J Neurooncol. 2010 Jan;96(2):231-9
references.pmid: 19575148
references.citation: AJR Am J Roentgenol. 2008 Jun;190(6):W365-9
references.pmid: 18492879
references.citation: Nucl Med Rev Cent East Eur. 2002;5(2):127-30
references.pmid: 14600871
references.citation: Mol Imaging Biol. 2009 Sep-Oct;11(5):343-55
references.pmid: 19326172
references.citation: Med Decis Making. 2008 Sep-Oct;28(5):621-38
references.pmid: 18591542
references.citation: Eur J Nucl Med. 1999 Nov;26(11):1501-9
references.pmid: 10552096
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Eur J Nucl Med Mol Imaging. 2008 May;35(5):966-75
references.pmid: 18172642
references.citation: Eur J Nucl Med. 1998 Sep;25(9):1261-9
references.pmid: 9724375
references.citation: J Nucl Med. 2007 Apr;48(4):519-27
references.pmid: 17401087
references.citation: J Clin Epidemiol. 2005 Oct;58(10):982-90
references.pmid: 16168343
references.citation: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9
references.pmid: 15711980
references.citation: Nucl Med Biol. 2009 Oct;36(7):779-87
references.pmid: 19720290
references.citation: J Comput Assist Tomogr. 2011 Nov-Dec;35(6):679-84
references.pmid: 22082535
references.citation: Clin Nucl Med. 2012 Feb;37(2):158-63
references.pmid: 22228339
references.citation: Chin Med J (Engl). 2012 Jan;125(1):91-6
references.pmid: 22340472
references.citation: J Nucl Med. 2008 May;49(5):694-9
references.pmid: 18413375
references.citation: AJNR Am J Neuroradiol. 2013 May;34(5):944-50, S1-11
references.pmid: 23124638
references.citation: Clin Neurol Neurosurg. 2010 Nov;112(9):758-65
references.pmid: 20619531
references.citation: Eur J Radiol. 2012 Mar;81(3):508-13
references.pmid: 21353420
references.citation: Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):134-8
references.pmid: 19538892
references.citation: J Clin Neurosci. 2010 Jan;17(1):43-9
references.pmid: 20004582
references.citation: AJR Am J Roentgenol. 1994 Dec;163(6):1459-65
references.pmid: 7992747
references.citation: Ann Neurol. 1993 May;33(5):540-8
references.pmid: 8498831
references.citation: Neurol Med Chir (Tokyo). 1998 Jun;38(6):342-7; discussion 347-8
references.pmid: 9689817
references.citation: Science. 1988 Jun 3;240(4857):1285-93
references.pmid: 3287615
references.citation: Neurol Med Chir (Tokyo). 2009 Sep;49(9):394-401
references.pmid: 19779283